United States - English - NLM (National Library of Medicine)

u.s. pharmaceutical corporation - fish oil (unii: xgf7l72m0f) (fish oil - unii:xgf7l72m0f), lacticaseibacillus casei (unii: sa940p2u00) (lacticaseibacillus casei - unii:sa940p2u00) -

United States - English - NLM (National Library of Medicine)

bayer pharmaceuticals corp - clotrimazole (unii: g07gz97h65) - troche - 10 mg - mycelex® troches are indicated for the local treatment of oropharyngeal candidiasis.the diagnosis should be confirmed by a koh smear and/or culture prior to treatment. mycelex® troches are also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. there are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (see dosage and administration .) mycelex® troches are contraindicated in patients who are hypersensitive to any of its components. no data available.

United States - English - NLM (National Library of Medicine)

us pharmaceutical corporation - calcium ascorbate (unii: 183e4w213w) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyano - ascorbic acid 30 mg

United States - English - NLM (National Library of Medicine)

us pharmaceutical corporation - boric acid (unii: r57zhv85d4) (boric acid - unii:r57zhv85d4) - boric acid 2 [hp_x] - hylafem is a homeopathic prescription to - treat vaginal yeast infection. - rebalance vaginal ph and restore normal vaginal health. - help relieve symptoms of internal and external vaginal burning, itching, and irritation. - help reduce vaginal foul odor due to vaginal infection. before taking hylafem, consult a doctor - if you are pregnant or nursing. boric acid should not be used in pregnant women due to the risk of teratogenic effects and the lack of data demonstrating safety. no data is available regarding the safety of boric acid in lactating mothers; therefore, it should not be recommended in this patient population. - if you have any other health problems such as high blood pressure or heart or blood vessel disease. - if you are an immune-compromised patient. - if you have open wounds, vaginal bleeding, sores, ulcerations, nausea, fever or chills, sensitivity in your lower pelvis or abdomen, sexually transmitted disease (std) or pelvic inflammatory disease (pid).

United States - English - NLM (National Library of Medicine)

u.s. pharmaceutical corporation - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), iron (unii: e1uol152h7) (iron - unii:e1uol152h7) - ascorbic acid 40 mg

United States - English - NLM (National Library of Medicine)

larasan pharmaceutical corporation - camphor (natural) (unii: n20hl7q941) (camphor (natural) - unii:n20hl7q941) - camphor (natural) 7.79 g in 100 ml - topical analgesic for temporary relief of minor aches and pains of muscle and joints associated with simple arthritis, strains, cramps, bruises, and sprains

United States - English - NLM (National Library of Medicine)

u.s. pharmaceutical corporation - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ferrous asparto glycinate (unii: h7426rgb3l) (ferrous cation - unii:gw89581owr), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a) - ferrous fumarate 191.2 mg - description: each capsule contains: ferrous fumarate (anhydrous) ..................................191.1 mg polysaccharide iron complex..................................... 135.9 mg (equivalent to about 125 mg of elemental iron) folic acid ....................................................................................1 mg ascorbic acid (from proascorb c‡) ................................ 40 mg vitamin b3 (from proascorb c‡) ........................................3 mg clinical pharmacology: integra ftm is unique in that it utilizes two (2) different forms of iron, i.e., ferrous fumarate and polysaccharide iron complex (as cell-contracted akaganèite), making available a total of 125 mg of elemental iron per capsule as follows: ferrous fumarate (anhydrous)    191.1 mg polysaccharide iron complex (pic)    135.9 mg ferrous fumarate: provides about 62.5 mg of elemental iron per dose. ferrous fumarate is an anhydrous salt of a combination of ferrous iron and fumaric acid, containing 33% of iron per weight.

United States - English - NLM (National Library of Medicine)

us pharmaceutical corporation - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - folic acid 250 ug in 0.75 g

United States - English - NLM (National Library of Medicine)

us pharmaceutical corporation - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), iron polymaltose (unii: um5219h89v) (ferric cation - unii:91o4lml611), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), lactobacillus casei (unii: sa940p2u00) (lactobacillus casei - unii:sa940p2u00) - ascorbic acid 50 mg in 3 g

United States - English - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - triamterene 50 mg - dyrenium (triamterene) is indicated in the treatment of edema associated with congestive heart failure, cirrhosis of the liver and the nephrotic syndrome; steroid-induced edema, idiopathic edema and edema due to secondary hyperaldosteronism. dyrenium may be used alone or with other diuretics, either for its added diuretic effect or its potassium-sparing potential. it also promotes increased diuresis when patients prove resistant or only partially responsive to thiazides or other diuretics because of secondary hyperaldosteronism. usage in pregnancy . the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. diuretics are indicated in pregnancy (however, see preca